Related Experiment Video
Updated: Jun 25, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Apoptotic signaling induced by benzamide riboside: an in vitro study
Sujata Pathak1, Chandresh Sharma, H N Jayaram
1Department of Biochemistry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Abstract:
Benzamide riboside (BR) is a novel anticancer agent exhibiting potent cytotoxic activity in malignant cell lines. However, the mechanism of induction of apoptosis is not clear. The purpose of this study was to elucidate the apoptotic signaling induced by BR on different human cancer cell lines. Our results revealed that BR at a dose of 50 microM induces apoptosis in SiHa, Hep2, and Ca Ski cells as studied by morphology and flow cytometry. A downregulation of anti-apoptotic proteins Bcl-2 and Bcl-xL was observed, whereas the expression level of the pro-apoptotic protein Bax remained unaffected. An upregulation of p53 was observed while no change was seen on the level of apoptosis inducing factor (AIF). A significant increase in caspase-3 and -9 activities was seen, which was accompanied by PARP cleavage. Release of cytochrome c from the mitochondria to the cytosol was also observed. Taken together, the findings suggest that BR induces apoptosis in SiHa, Hep2, and Ca Ski cells via the intrinsic mitochondrial pathway.
Insights
Benzamide riboside (BR) effectively induces apoptosis in human cancer cells. This novel anticancer agent triggers the intrinsic mitochondrial pathway, offering a new therapeutic strategy for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Benzamide riboside (BR) is recognized as a potent anticancer agent with significant cytotoxic effects on various malignant cell lines.
- The precise molecular mechanisms underlying BR-induced apoptosis remain incompletely understood.
Purpose of the Study:
- To investigate and clarify the specific apoptotic signaling pathways activated by Benzamide riboside (BR) in diverse human cancer cell lines.
- To elucidate the role of key apoptotic proteins and cellular events in BR-mediated cell death.
Main Methods:
- Morphological analysis and flow cytometry were employed to assess apoptosis induction in SiHa, Hep2, and Ca Ski cells treated with BR.
- Western blotting and biochemical assays were used to evaluate the expression levels of apoptosis-related proteins (Bcl-2, Bcl-xL, Bax, p53, AIF) and the activity of caspases (caspase-3, caspase-9).
- Mitochondrial integrity was assessed by monitoring cytochrome c release into the cytosol.
Main Results:
- Benzamide riboside (BR) at 50 microM demonstrated significant apoptosis induction in SiHa, Hep2, and Ca Ski cells.
- BR treatment led to the downregulation of anti-apoptotic proteins Bcl-2 and Bcl-xL, while Bax expression remained unchanged.
- Increased p53 levels, elevated caspase-3 and -9 activities, PARP cleavage, and cytochrome c release from mitochondria were observed, indicating activation of the intrinsic apoptotic pathway.
Conclusions:
- Benzamide riboside (BR) effectively induces apoptosis in SiHa, Hep2, and Ca Ski cancer cells.
- The findings strongly suggest that BR activates apoptosis predominantly through the intrinsic mitochondrial pathway.
- BR's mechanism involves modulating Bcl-2 family proteins, activating caspases, and releasing cytochrome c, highlighting its potential as an anticancer therapeutic.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
The Extrinsic Apoptotic Pathway
